Intrinsic Value

The intrinsic value of Castle Biosciences Inc (086) under the Base Case is 0.43 EUR per share. Compared with the current market price of 0.8 EUR, the stock appears Overvalued by 46% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
€0.43
Overvaluation 46%
Intrinsic Value
Price €0.8
Alert me when Castle Biosciences Inc is below its intrinsic value
Today €0.35 · 56.8% below the current price
Alternatives to Castle Biosciences Inc

Fundamental Analysis

What Castle Biosciences Does

Health Care

Castle Biosciences makes laboratory tests that help doctors make treatment decisions for cancers and other skin-related conditions. Its best-known products are molecular diagnostic tests, including tests for melanoma and other skin cancers, that analyze tissue samples and give doctors more information about how aggressive a disease may be and how a patient may respond to treatment.

Headquarters
United States of America US
Employees
883
IPO date
Jul 25, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Castle Biosciences Inc

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

CSTL Insider Trading
Buy and sell transactions by insiders

Continue Research

Decided on Castle Biosciences? Get an email when Castle Biosciences Inc reaches the price you’d buy at. Free with an account.

Other Castle Biosciences listings

What is the Intrinsic Value of one Castle Biosciences Inc stock?

The intrinsic value for Castle Biosciences Inc (086) under the Base Case is 0.43 EUR.

Is Castle Biosciences Inc stock undervalued or overvalued?

Compared with the current market price of 0.8 EUR, the stock appears Overvalued by 46% .

How reliable are our estimates? See how past valuations played out
Back to Top